Consenso elaborado por la Sociedad Chilena de Endocrinología y Diabetes sobre resistencia a la insulina(RI) y síndrome metabólico (SM): aspectos clínicos y terapéuticos / Chilean society of endocrinology and diabetes consensus on clinical and therapeutic aspects of insulin resistance and metabolic syndrome
Rev. chil. endocrinol. diabetes
; 1(4): 272-281, oct. 2008. tab
Article
en Es
| LILACS
| ID: lil-612484
Biblioteca responsable:
CL1.1
ABSTRACT
Background:
The concept insulin resistance as the basis for a series of metabolic alterations and diseases was introduced by Gerald Reaven in 1988, when he described a cluster of alterations that named syndrome X.Aim:
To review and discuss the present information about insulin resistance (IR) and metabolic syndrome (MS). Material andmethods:
The IR concept is defined,the affected metabolic ways, its consequences and relationship with different diseases are presented. The importance of central obesity with its metabolic, inflammatory and prothrombotic consequences playing a key role in cardiovascular risk, is discussed. The cluster of factors focused on cardiovascular disease and eventually diabetes is named MS. Several definitions of MS are analyzed and compared. A proposition is made about the definition to be used in the Chilean population. Differences between IR syndrome and MS are discussed. Diagnostic methods of IR and MS are presented, recommendations are made about their usefulness and reliability. Non pharmacological and pharmacological treatments of IR and MS are analyzed. Other related diseases, such as polycystic ovary syndrome, non alcoholic steatohepatitis and sleep apnea are discussed. Conclusions. Until further studies are made to define a local waist circumference cut-off associated with high risk, the ATPIII MS definition is preferred. A clinical approach is recommended for diagnosis. A search for all components of the MS is important. There is no evidence about the benefits of MS treatment on the prevention of cardiovascular diseases or diabetes. Evidence supports the use of lifestyle changes and some drugs, such as metformin on the prevention of diabetes in prediabetic states.
Buscar en Google
Colección:
01-internacional
Base de datos:
LILACS
Asunto principal:
Síndrome Metabólico
Tipo de estudio:
Guideline
Límite:
Humans
País/Región como asunto:
America do sul
/
Chile
Idioma:
Es
Revista:
Rev. chil. endocrinol. diabetes
/
Revista chilena de endocrinología y diabetes
Asunto de la revista:
ENDOCRINOLOGIA
Año:
2008
Tipo del documento:
Article
País de afiliación:
Chile
Pais de publicación:
Chile